🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Brain Cancer

ioMRI in the Surgery of Brain Metastases. NCT07197632NA1 site📍 Munich Technical University of Munich · Tests: Surgery with intraoperative MRI Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis NCT06933199NA4 sites📍 Ostrava📍 Brno📍 Hradec Králové University Hospital Ostrava · Tests: Neoadjuvant Stereotactic Radiotherapy (NaSRT), Postoperative Stereotactic Radiotherapy (SRT) Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends NCT07341464NA2 sites📍 Nottingham📍 Worcester Société des Produits Nestlé (SPN) · Tests: Tube feed RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention NCT06553235NA1 site📍 Aarhus N Aarhus University Hospital · Tests: Cognitive Behavioral Therapy for Insomnia (CBT-I), Sleep hygiene education Florida Center for Brain Tumor Research NCT00811148n/a1 site📍 Gainesville University of Florida · Tests: Tissue Bank Sonodynamic Therapy in Patients With Recurrent GBM NCT06039709Phase 11 site📍 Charlottesville Shayan Moosa, MD · Tests: 5-ALA and Low-Intensity Focused Ultrasound (SDT) A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases NCT05033691NA1 site📍 Jerusalem Hadassah Medical Organization · Tests: Stereotactic surgery Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours NCT06951659n/a1 site📍 Perth The University of Western Australia Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. NCT07463625n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Data-only evaluation of [18F]FET PET, pituitary MRI, and biomarkers Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies NCT06199479Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: MRI Scan, CT Scan, Biopsy A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas NCT07003542Phase 21 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Sitagliptin Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer NCT06072807Phase 41 site📍 New York Weill Medical College of Cornell University · Tests: Brain Imaging with 18F-FES Cognitive Function After Radiation Therapy for Primary Brain Tumours NCT04306432n/a5 sites📍 Copenhagen📍 Aarhus📍 Aarhus University of Aarhus · Tests: Cognitive tests and Patient Reported Outcomes Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants NCT04987463Phase 2, Phase 32 sites📍 Warsaw📍 Warsaw Katarzyna Kotulska · Tests: Vigabatrin, Rapamycin, Placebo, Placebo Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases NCT05866432Phase 21 site📍 Vienna Medical University of Vienna · Tests: Datopotamab deruxtecan Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions NCT04047264NA1 site📍 Rochester Mayo Clinic · Tests: Microdialysis, Magnetic Resonance Imaging, Computed Tomography EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active NCT06649058Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Systemic Therapy, Stereotactic Radiosurgery Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study NCT04962672NA1 site📍 Toronto University Health Network, Toronto · Tests: Propofol group, Sevoflurane group Neurosurgical Outcome Network NCT06724029n/a27 sites📍 Bergamo📍 Brescia📍 Brescia Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma NCT05535166Phase 210 sites📍 Palo Alto📍 Orlando📍 Tampa St. Jude Children's Research Hospital · Tests: Surgical resection, Ommaya/VPS, Methotrexate, Cisplatin, Vincristine Feasibility Study of a Co-Designed Gamified Medical Yoga App for Home-Based Cancer Rehabilitation NCT07872956NA1 site📍 Linköping Linkoeping University · Tests: Medical yoga Posterior Fossa Intracranial Pressure (ICP) Measurement: Clinical Study NCT04675216n/a2 sites📍 Valencia📍 Valencia University of Valencia · Tests: Posterior fossa intracranial pressure measurement DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs NCT06176261Phase 23 sites📍 Miami📍 Boston📍 Durham Nancy Lin, MD · Tests: Datopotamab Deruxtecan Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery NCT07767981n/a1 site📍 Chicago University of Chicago Combined Gamma Knife/Linac Radiosurgery for Large Brain Tumors / Metastases NCT07162246Phase 21 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Radiation Therapy WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases NCT06243003Phase 1, Phase 21 site📍 Shanghai Fudan University · Tests: HA-WBRT plus SBRT Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA NCT01269853Phase 1, Phase 21 site📍 New York Northwell Health · Tests: Bevacizumab, Bevacizumab Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO] NCT06466031NA1 site📍 Lodz Copernicus Memorial Hospital · Tests: MRI & PET fusion, MRI+T1C Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas NCT06687681Phase 21 site📍 Tehran Marzieh Ebrahimi · Tests: NK cell therapy Atamparib in Patients With Advanced Solid Tumors NCT07374419Phase 1, Phase 21 site📍 Shanghai Nerviano Medical Sciences (Shanghai) Ltd. · Tests: atamparib escalation levels, atamparib RP2D
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy